Lowther, D. E., Weinhold, K., Reap, E., Vlahovic, G., Omuro, A., Sahebjam, S., . . . Sampson, J. (2015). CBM-06 IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143. Neuro Oncol.
Styl cytowania ChicagoLowther, Daniel E., et al. "CBM-06 IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143." Neuro Oncol 2015.
Styl cytowania MLALowther, Daniel E., et al. "CBM-06 IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143." Neuro Oncol 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..